CLR-180099

N/A

Report date: 2024/11/13 15:52:54

Base Information

Drug NameCLR-180099
Drug Alias NameCLR 180099CLR-180099
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionPhospholipids modulators
TargetsPhospholipids
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre LtdCellectar Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellectar Biosciences IncPierre Fabre Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A